STOCK TITAN

HUNTINGTON BANCSHARES /MD/ (HBAN) SEC Filings, Oct 3, 2025

HBAN NASDAQ

Huntington Bancshares Incorporated filings document the regulatory record of a regional bank holding company with Nasdaq-listed common stock and preferred depositary shares. The company's Form 8-K filings record dividend declarations on common and preferred stock, Regulation FD presentations, shareholder-vote results, and other material-event disclosures.

Definitive proxy statements cover annual meeting proposals, director elections, executive compensation, shareholder voting matters, and governance practices. Filing disclosures also identify Huntington's capital structure, including common stock and depositary shares representing interests in non-cumulative perpetual preferred stock, along with operating and financial results, risk factors, and other bank holding company reporting subjects.

Rhea-AI Summary

Zachary Jacob Wasserman, identified as CFO and Senior Exec. V.P. of HUNTINGTON BANCSHARES INC (HBAN), reported an acquisition on 10/01/2025 of 2,434.987 shares of common stock with a reported price of $0.0000 (indicative of a grant or non‑cash issuance). After the transaction he beneficially owns 282,176.164 shares. The Form 4 was signed by an attorney‑in‑fact on 10/03/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.91%
Tags
insider
-
Rhea-AI Summary

Jeffrey L. Tate, a director of Huntington Bancshares Inc. (HBAN), reported acquisitions on 10/01/2025 under a director deferred compensation arrangement. The filing shows 461.241 shares of common stock acquired at a stated price of $0.0000, increasing his direct holdings to 112,657.268 shares. An additional 45.238 shares were recorded as indirect holdings, bringing that total to 5,063.708 shares. The Form 4 includes an Exhibit 24 power of attorney and was signed by an attorney-in-fact on 10/03/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.91%
Tags
insider
-
Rhea-AI Summary

Stephen D. Steinour, who is listed as President, CEO & Chairman and a Director of Huntington Bancshares Inc. (HBAN), filed a Form 4 disclosing non-derivative stock transactions dated 10/01/2025. The filing reports two acquisitions of common stock on that date: 6,326.503 shares and 491.145 shares, each recorded with a price of $0.0000. Following the reported transactions the document lists a total direct beneficial holding of 1,872,763.404 shares and various indirect holdings allocated to plans and trusts, including 3,441,119.559, 2,898,505, 496,500, 90,363.268, and other smaller allocations as shown in the filing. The Form 4 includes an exhibit index reference to a substitute power of attorney and is signed by an attorney-in-fact on 10/03/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.91%
Tags
insider
Rhea-AI Summary

Brantley J. Standridge, identified as Senior Exec. V.P. of Huntington Bancshares Inc. (HBAN), reported an acquisition of 2,376.67 shares of Common Stock on 10/01/2025 via a Form 4. The reported transaction lists a price of $0.0000 and shows 331,168.429 shares beneficially owned following the transaction. The filing includes an Exhibit 24 substitute power of attorney and was signed on behalf of the reporting person by Rachel L. Lawless, Attorney-in-Fact on 10/03/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.91%
Tags
insider
-
Rhea-AI Summary

Roger J. Sit, a director of HUNTINGTON BANCSHARES INC /MD/ (HBAN), reported purchases on 10/01/2025. The Form 4 shows a direct acquisition of 1,514.358 shares (transaction code A) at a reported price of $0.0000, leaving 193,110.333 shares held directly after the transaction. The filing also reports an indirect acquisition of 357.324 shares, bringing indirect holdings to 39,997.025 shares via several vehicles: 22,921 shares in the Director Deferred Compensation Plan, 152,572 shares by the Richard A. Sit Trust, 4,713 shares by a trust, and 152,572 noted for Sit Investment Associates.

The filing includes an exhibit: Exhibit 24 (Substitute Power of Attorney), and is signed by Rachel L. Lawless, Attorney-in-Fact on 10/03/2025. The filer clarifies the statement is not an admission of beneficial ownership for Section 16 purposes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.91%
Tags
insider
-
Rhea-AI Summary

Huntington Bancshares (HBAN) director Teresa H. Shea reported acquisitions on a Form 4 dated 10/01/2025. The filing shows an acquisition of 182.758 shares of Common Stock directly and 50.96 shares indirectly under the Director Deferred Compensation Plan, for a combined 233.718 shares. The reported price for both entries is $0.0000, and the holdings after the transactions are 21,274.515 shares held directly and 5,704.219 shares held indirectly. The filer is identified as a Director, and the Form was filed by one reporting person.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.91%
Tags
insider
Rhea-AI Summary

Katherine M. A. Kline, a Director of Huntington Bancshares Inc. (HBAN), filed a Form 4 reporting transactions dated 10/01/2025. The filing reports the acquisition of 800.06 shares of common stock and an additional acquisition of 44.026 shares attributable to a director deferred compensation plan, both shown at a price of $0.0000. After the reported transactions, the filing lists 88,755.371 shares as directly beneficially owned and 4,927.986 shares as indirectly beneficially owned via the deferred compensation plan.

The Form 4 identifies the reporting persons address as Huntington Center, 41 S. High Street, Columbus, OH 43215 and includes an exhibit index reference to a substitute power of attorney. The filing contains the signature of an attorney-in-fact dated 10/03/2025. The statement clarifies that the filing is not an admission of beneficial ownership for Section 16 purposes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.91%
Tags
insider
-
Rhea-AI Summary

David L. Porteous, a director of HUNTINGTON BANCSHARES INC /MD/ (HBAN), reported multiple acquisitions of common stock on 10/01/2025. The Form 4 shows acquisitions recorded as 1,268.493, 640.262, 140.739, and 1,062.201 shares under various accounts including an IRA, SEP-IRA, and a Director Deferred Compensation Plan, each with a reported price of $0.0000. The filing also lists 10,136.631 shares indicated as indirect ownership by spouse. The filer disclaims that the statement is not an admission of beneficial ownership. The form is signed by Rachel L. Lawless as attorney-in-fact on 10/03/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.91%
Tags
insider
-
Rhea-AI Summary

Sarah E. Pohmer, SEVP-CHRO of Huntington Bancshares Inc. (HBAN), reported an insider purchase on 10/01/2025. The filing shows acquisition of 1,114.393 shares of common stock at a price of $0.0000 (indicating a grant or similar non‑cash issuance). After the transaction she beneficially owns 153,205.126 shares. The Form 4 was signed by attorney‑in‑fact Rachel L. Lawless on 10/03/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.91%
Tags
insider
Rhea-AI Summary

Kenneth J. Phelan, a director of HUNTINGTON BANCSHARES INC (HBAN), reported acquisitions of Common Stock on 10/01/2025. The Form 4 shows two non-derivative stock entries: 851.349 shares acquired (direct) and 483.095 shares acquired (indirect via the Director Deferred Compensation Plan), both at a reported price of $0.0000 for record purposes.

Following these transactions, the filing reports total beneficial ownership of 134,445.125 shares directly and 54,075.157 shares indirectly. The filing includes an exhibit (Exhibit 24) naming a substitute power of attorney and is signed by an attorney-in-fact on 10/03/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.91%
Tags
insider

FAQ

How many HUNTINGTON BANCSHARES /MD/ (HBAN) SEC filings are available on StockTitan?

StockTitan tracks 313 SEC filings for HUNTINGTON BANCSHARES /MD/ (HBAN), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for HUNTINGTON BANCSHARES /MD/ (HBAN)?

The most recent SEC filing for HUNTINGTON BANCSHARES /MD/ (HBAN) was filed on November 10, 2026.